Lv53
1129 积分 2024-08-26 加入
TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis: a randomised, placebo-controlled, phase 2 trial of BI 764198
2天前
已完结
Osteoarthritis and chronic pain: Interleukin-6 as a common denominator and therapeutic target
1个月前
已完结
A patent review of xanthine oxidase inhibitors (2021–present)
1个月前
已完结
BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration
1个月前
已完结
Inhibition of 15-hydroxy prostaglandin dehydrogenase promotes cartilage regeneration
2个月前
已完结
Taladegib for the treatment of idiopathic pulmonary fibrosis (ENV-IPF-101): a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial
2个月前
已完结
NUC7738 Induces Apoptosis Through Modulating Stability of P53 in Esophageal Cancer Cells
2个月前
已完结
Low-dose dengue virus 3 human challenge model: a phase 1 open-label study
3个月前
已完结
Benefit-Risk Profile of P2X3 Receptor Antagonists for Treatment of Chronic Cough
3个月前
已完结
A non-human primate model for human norovirus infection
3个月前
已完结
皖公网安备34019202002308
